Basic information Safety Supplier Related

vanicoside B

Basic information Safety Supplier Related

vanicoside B Basic information

Product Name:
vanicoside B
Synonyms:
  • vanicoside B
  • α-D-Glucopyranoside, 1,3,6-tris-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-β-D-fructofuranosyl, 6-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate]
CAS:
155179-21-8
MF:
C49H48O20
MW:
956.89
Mol File:
155179-21-8.mol
More
Less

vanicoside B Chemical Properties

Melting point:
157-159 °C
Boiling point:
1165.0±65.0 °C(Predicted)
Density 
1.54±0.1 g/cm3(Predicted)
pka
9.67±0.26(Predicted)
form 
Solid
color 
White to off-white
More
Less

vanicoside B Usage And Synthesis

Uses

Vanicoside B is a phenylpropanoyl sucrose derivative, can be isolated from the herb Persicaria dissitiflora. Vanicoside B targets cyclin-dependent kinase 8 (CDK8) and exhibits anti-tumor activity. The potential mechanism is Vanicoside B blocks CDK8-mediated signaling pathways and decreases the expression of epithelial-mesenchymal transition proteins, so that it leads to cell cycle arrest and apoptosis[1][2].

in vivo

Vanicoside B (5 mg/kg and 20 mg/kg; i.p.; 3 times per week for 4 weeks) inhibits tumor growth in xenografted mouse models with MDAMB-231 cells[1].

Animal Model:MDA-MB-231 cell-implanted xenograft mouse model[1]
Dosage:5 mg/kg, 20 mg/kg
Administration:Intraperitoneal injection; 3 times per week over 4 weeks
Result:Significantly reduced tumor volumes at 5 mg/kg and 20 mg/kg by 53.85% and 65.72%, respectively.

IC 50

CDK3; STAT3

References

[1] Kim D, et al. Antitumor Activity of Vanicoside B Isolated from Persicaria dissitiflora by Targeting CDK8 in Triple-Negative Breast Cancer Cells. J Nat Prod. 2019 Nov 22;82(11):3140-3149. DOI:10.1021/acs.jnatprod.9b00720
[2] Takasaki M, et al. Cancer chemopreventive activity of phenylpropanoid esters of sucrose, vanicoside B and lapathoside A, from Polygonum lapathifolium. Cancer Lett. 2001 Nov 28;173(2):133-8. DOI:10.1016/s0304-3835(01)00670-x

vanicoside BSupplier

Sichuan Wei Keqi Biological Technology Co., Ltd.
Tel
028-81700200 18116577057
Email
3003855609@qq.com
Wuhan ChemFaces Biochemical Co., Ltd.
Tel
18607101326 15172504745
Email
aileen@chemfaces.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
BioBioPha Co., Ltd.
Tel
0871-65217109
Email
y.liu@mail.biobiopha.com
Shanghai Bohu Biotechnology Co., LTD
Tel
021-57763112 13585886131
Email
3004987436@qq.com